Lysozyme‐induced nephropathy due to systemic granulomatous disease
Clinical Case Reports · 2023-11 · 11 (11)
DOI: 10.1002/ccr3.8122 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Case Reports, online erschienen am 19.11.2023. Verfasst von Hamza Ashraf und 2 weiteren Autor:innen. Beteiligte Einrichtung: Overlook Medical Center Atlantic Health System Summit New Jersey USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Key Clinical Message Lysozyme‐induced nephropathy is a rare form of acute tubular injury that has almost exclusively been reported in patients with monocytic malignancies. Typically, patients will present in acute renal failure A renal biopsy is necessary to confirm the diagnosis and will demonstrate proximal tubular cells with hypereosinophilic granules, which are periodic acid‐Schiff and Jones methenamine silver‐positive. Immunohistochemical staining for lysozyme will also be present. The following rare case will describe a case of lysozyme nephropathy in a patient without any underlying hematological malignancy, but instead with systemic granulomatous disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Overlook Medical Center Atlantic Health System Summit New Jersey USA.
ORCID-Profile: Hamza Ashraf, Dariusz Uczkowski
Zitieren
APA
Ashraf, H., Uczkowski, D., & Stuart, M. (2023). Lysozyme‐induced nephropathy due to systemic granulomatous disease. Clinical Case Reports, 11(11). https://doi.org/10.1002/ccr3.8122
Vancouver
Ashraf H, Uczkowski D, Stuart M. Lysozyme‐induced nephropathy due to systemic granulomatous disease. Clinical Case Reports. 2023;11(11). doi:10.1002/ccr3.8122
BibTeX
@article{Ashraf2023,
author = {Ashraf, Hamza and Uczkowski, Dariusz and Stuart, Matthew},
title = {Lysozyme‐induced nephropathy due to systemic granulomatous disease},
journal = {Clinical Case Reports},
year = {2023},
volume = {11},
number = {11},
doi = {10.1002/ccr3.8122}
}
EUVIMED